Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00573040
What this trial is testing

Radiotherapy for NSCLC to a Individualized MLD

Who this might be right for
Non-small Cell Lung Cancer
Maastricht Radiation Oncology 180
Not applicableStudy completedNCT02843568
What this trial is testing

Improving Pulmonary Function Following Radiation Therapy

Who this might be right for
Non-Small Cell Lung Cancer
University of Wisconsin, Madison 122
Testing effectiveness (Phase 2)Looking for participantsNCT06542250
What this trial is testing

Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Who this might be right for
B-cell Malignancies
AstraZeneca 174
Testing effectiveness (Phase 2)Ended earlyNCT00522990
What this trial is testing

Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+2 more
Astex Pharmaceuticals, Inc. 48
Not applicableStudy completedNCT04501497
What this trial is testing

Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

Who this might be right for
Non-small Cell Lung CancerExtensive Disease Small Cell Lung Cancer
Chugai Pharmaceutical 1,221
Not applicableApproved For MarketingNCT04504513
What this trial is testing

Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer

Who this might be right for
Myelosuppression AdultChemotherapeutic ToxicitySmall Cell Lung Cancer
G1 Therapeutics, Inc.
Early research (Phase 1)Study completedNCT05926180
What this trial is testing

Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)

Who this might be right for
Non-small Cell Lung Cancer
Dizal Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00324779
What this trial is testing

Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaLymphoma
University Hospital Erlangen 79
Large-scale testing (Phase 3)Ended earlyNCT02974426
What this trial is testing

To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IIIARadiotherapy
Shanghai Chest Hospital 132
Not applicableUnknownNCT03454685
What this trial is testing

The Role of Microbiota on the Development of Lung Cancer

Who this might be right for
NSCLC, Stage INSCLC, Stage IINSCLC, Stage III+2 more
Xiaorong Dong 100
Not applicableStudy completedNCT06495008
What this trial is testing

Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

Who this might be right for
MelanomaNon-small Cell Lung Cancer (NSCLC)Urogenital Cancers
University Medical Center Groningen 101
Early research (Phase 1)Ended earlyNCT00531076
What this trial is testing

Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer

Who this might be right for
Toxicity
Amsterdam UMC, location VUmc 6
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Testing effectiveness (Phase 2)UnknownNCT03700359
What this trial is testing

Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC

Who this might be right for
Small Cell Lung Carcinoma
The First Affiliated Hospital of Guangzhou Medical University 60
Testing effectiveness (Phase 2)UnknownNCT01503385
What this trial is testing

Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Chinese Academy of Medical Sciences 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05825625
What this trial is testing

NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing

Who this might be right for
Non-small Cell Lung Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 35
Testing effectiveness (Phase 2)Study completedNCT02994576
What this trial is testing

Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 60
Testing effectiveness (Phase 2)Study completedNCT00193310
What this trial is testing

Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 250
Early research (Phase 1)Ended earlyNCT00543335
What this trial is testing

Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07545213
What this trial is testing

Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis

Who this might be right for
Non-small Cell Lung CancerEGFR Mutant Advanced Non-small Cell Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 27
Next Page